Heather Ipema, Erika Maslennikov, Faria Munir, Patricia Hartke, Ruba Alomari, Anna Dazy, Alexandra Wierzbiak
{"title":"Actionable Renal Dosing Content for Nephrotoxic Medications in 4 Drug Information Resources Commonly Used in the United States.","authors":"Heather Ipema, Erika Maslennikov, Faria Munir, Patricia Hartke, Ruba Alomari, Anna Dazy, Alexandra Wierzbiak","doi":"10.1177/08971900251364049","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction:</b> Inclusion of numeric, actionable renal dosing recommendations in drug information resources enhances the safe use of nephrotoxins. <b>Purpose:</b> The purpose of this study was to systematically and descriptively characterize the renal dose recommendations for nephrotoxic medications in 4 common drug information resources. <b>Methods:</b> A list of nephrotoxins (N = 154) was generated from previously published lists. Renal dosing information was collected for each drug from the package insert, Lexi-comp (now called UpToDate Lexidrug), Micromedex, and Clinical Pharmacology. Dosing recommendations were categorized using a previously published 6-category scale based on whether recommendations were included vs missing, and numeric vs non-numeric. <b>Results:</b> Actionable renal impairment recommendations (numeric, non-numeric, contraindicated, no dose adjustment required) in the package insert, Lexi-comp, Micromedex, and Clinical Pharmacology were present for 88.3%, 98.1%, 94.2%, and 98.1% of drugs, respectively. Numeric recommendations were available for 54.5% to 75.3% of medications, depending on the source. Actionable recommendations for hemodialysis, peritoneal dialysis, continuous renal replacement, and hybrid dialysis modalities were more common in Lexi-comp (83.1%, 75.3%, 62.3%, and 53.9% of medications, respectively) vs the other resources. Actionable pediatric renal impairment (76.0%) and older adult (95.5%) recommendations were also more common in Lexi-comp than other resources. <b>Conclusions:</b> Drug information resources included actionable renal dosing recommendations for most known nephrotoxins, with Lexi-comp being most likely to include this information. Numeric and/or actionable recommendations for specific dosing populations (eg, renal replacement modalities, pediatric renal impairment, older adults) were generally lacking. Lack of agreement among resources suggests a need to check multiple sources in practice.</p>","PeriodicalId":16818,"journal":{"name":"Journal of pharmacy practice","volume":" ","pages":"8971900251364049"},"PeriodicalIF":1.1000,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmacy practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/08971900251364049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Inclusion of numeric, actionable renal dosing recommendations in drug information resources enhances the safe use of nephrotoxins. Purpose: The purpose of this study was to systematically and descriptively characterize the renal dose recommendations for nephrotoxic medications in 4 common drug information resources. Methods: A list of nephrotoxins (N = 154) was generated from previously published lists. Renal dosing information was collected for each drug from the package insert, Lexi-comp (now called UpToDate Lexidrug), Micromedex, and Clinical Pharmacology. Dosing recommendations were categorized using a previously published 6-category scale based on whether recommendations were included vs missing, and numeric vs non-numeric. Results: Actionable renal impairment recommendations (numeric, non-numeric, contraindicated, no dose adjustment required) in the package insert, Lexi-comp, Micromedex, and Clinical Pharmacology were present for 88.3%, 98.1%, 94.2%, and 98.1% of drugs, respectively. Numeric recommendations were available for 54.5% to 75.3% of medications, depending on the source. Actionable recommendations for hemodialysis, peritoneal dialysis, continuous renal replacement, and hybrid dialysis modalities were more common in Lexi-comp (83.1%, 75.3%, 62.3%, and 53.9% of medications, respectively) vs the other resources. Actionable pediatric renal impairment (76.0%) and older adult (95.5%) recommendations were also more common in Lexi-comp than other resources. Conclusions: Drug information resources included actionable renal dosing recommendations for most known nephrotoxins, with Lexi-comp being most likely to include this information. Numeric and/or actionable recommendations for specific dosing populations (eg, renal replacement modalities, pediatric renal impairment, older adults) were generally lacking. Lack of agreement among resources suggests a need to check multiple sources in practice.
期刊介绍:
The Journal of Pharmacy Practice offers the practicing pharmacist topical, important, and useful information to support pharmacy practice and pharmaceutical care and expand the pharmacist"s professional horizons. The journal is presented in a single-topic, scholarly review format. Guest editors are selected for expertise in the subject area, who then recruit contributors from that practice or topic area.